We’re thrilled to announce that we have partnered with iNGENū CRO to design and conduct two clinical trials to evaluate our patented NeuroDirect™ ketamine topical delivery system for treating #PTSD.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.